Tucatinib

TUKYSA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

157,2 mg comprimido recubierto con películaSpainMarketedAuthorised 4 Mar 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

TukysaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tucatinib

TUKYSA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

157,2 mg comprimido recubierto con películaSpainMarketedAuthorised 4 Mar 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

TukysaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tukysa 50 mg, filmomhulde tabletNetherlands · Filmomhulde tablet · Pfizer Europe MA EEIG

TukysaSaudi Arabia · Corden Pharma GmbH

TUKYSA (TUCATINIB) FILM-COATED TABLETS 150 mgSingapore · 150mg · tablet, film coated · Pfizer Private Limited

TUKYSA (TUCATINIB) FILM-COATED TABLETS 50 mgSingapore · 50mg · tablet, film coated · Pfizer Private Limited

TukysaUnited States · 150MG, 50MG · tablet · Seagen

Packs

Pack	Code	Status
TUKYSA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 84 comprimidos	730461

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tucatinib
Strength: 157,2 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 4 Mar 2021
Registration: 1201526002
Marketing authorisation holder: Pfizer Europe Ma Eeig
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/20/1526